1. Home
  2. TECH vs HSIC Comparison

TECH vs HSIC Comparison

Compare TECH & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$65.48

Market Cap

9.2B

Sector

Health Care

ML Signal

HOLD

Logo Henry Schein Inc.

HSIC

Henry Schein Inc.

HOLD

Current Price

$75.13

Market Cap

9.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECH
HSIC
Founded
1976
1932
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2B
9.1B
IPO Year
1989
1995

Fundamental Metrics

Financial Performance
Metric
TECH
HSIC
Price
$65.48
$75.13
Analyst Decision
Buy
Hold
Analyst Count
14
13
Target Price
$70.46
$76.00
AVG Volume (30 Days)
2.1M
1.2M
Earning Date
02-04-2026
02-24-2026
Dividend Yield
0.47%
N/A
EPS Growth
N/A
30.70
EPS
0.49
3.17
Revenue
$1,216,732,000.00
$12,938,000,000.00
Revenue This Year
$2.33
$5.34
Revenue Next Year
$6.89
$3.42
P/E Ratio
$140.18
$24.26
Revenue Growth
3.85
3.51
52 Week Low
$46.01
$60.56
52 Week High
$79.28
$82.49

Technical Indicators

Market Signals
Indicator
TECH
HSIC
Relative Strength Index (RSI) 50.90 44.03
Support Level $66.94 $77.53
Resistance Level $68.54 $79.44
Average True Range (ATR) 2.45 1.91
MACD -0.22 -0.36
Stochastic Oscillator 26.11 21.73

Price Performance

Historical Comparison
TECH
HSIC

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About HSIC Henry Schein Inc.

Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.

Share on Social Networks: